Catalyst Pharmaceuticals, Inc.
Board Member
2025-08-01–present
Daniel J. Curran, M.D.
Board Member
Catalyst Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel J. Curran, M.D.
Daniel J. Curran, M.D. is recorded as Board Member at Catalyst Pharmaceuticals, Inc.. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed July 16, 2026 that Daniel J. Curran, M.D. resigned as director, effective July 15, 2026. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed July 8, 2026 that Daniel J. Curran, M.D. resigned as member of the board of directors of the Company and any committee thereof. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed August 4, 2025 that Daniel J. Curran, M.D. was appointed Board of Directors, effective August 1, 2025.
“as of the Effective Time, each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.”
“each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Catalyst Pharmaceuticals, Inc.
Board Member
SEC 8-K
Current2025-08-01–present
-
Catalyst Pharmaceuticals, Inc.
Board Member
SEC 8-K
2025-08-04–2026-07-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
-
Executive change Resigned: member of the board of directors of the Company and any committee thereof
Catalyst Pharmaceuticals, Inc.
-